The Future of Manufacturing: Collaborative Robots in the Factories The Collaborative Robots Market, 2020-2030” report features an extensive study of the potential applications, current landscape and the likely adoption of cobots across various industrial applications, over the next decade. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. For more information, please click on the following link: https://www.rootsanalysis.com/reports/collaborative-robots-market.html

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030 Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030 Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices were instrumental in increasing diagnostic throughput since they could be easily sterilized For additional details, please visit https://www.rootsanalysis.com/reports/handheld-x-ray-imaging-devices-market.html

The clinical trials software market is projected to be growing at a CAGR of 14% Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and software solutions for conducting clinical trials For additional details, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html

The site management organizations (SMO) market is projected to grow at an annualized rate of ~10% during the period 2021-2035 The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented lucrative opportunities for service providers with expertise in clinical trial site management For additional details, please visit https://www.rootsanalysis.com/reports/site-management-organizations-market.html

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved For additional details, please visit https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html

The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7%, till 2031, claims Roots Analysis Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic For additional details, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

CELL AND GENE THERAPIES; MOST COMMONLY OFFERED SERVICES During our research, we were able to capture more than 40 players, which claims to offer bioassay services related for cell and gene therapies. For additional details, please visit https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.html

The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030 Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations For additional details, please visit https://www.rootsanalysis.com/reports/squamous-non-small-cell-lung-cancer-market.html